Personalized medicine in oncology: Tailoring the right drug to the right patient

Yuqiu Jiang, Mu Wang*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

35 Citations (Scopus)


Despite advances in the management of many human cancers over the past few decades, improvements in survival are marginal, and the overall diagnosis and prognosis for cancer patients remain poor. Tailoring therapy to the individual patient has become a promising approach for maximizing efficacy and minimizing drug toxicity. Aided by major technological advances, the field of personalized medicine has become extremely active in the identification of predictive biomarkers that can guide treatment decisions and, ultimately, improve treatment outcomes. Genomics and proteomics have provided a means for molecular profiling that allows tailoring of therapy. Although implementing genomic and proteomic testing into clinical practice is still in its infancy, the rapid development of newer technologies and platforms provides hope for personalized medicine.

Original languageEnglish
Pages (from-to)523-533
Number of pages11
JournalBiomarkers in Medicine
Issue number4
Publication statusPublished - Aug 2010
Externally publishedYes


  • biomarker
  • cancer
  • genomics
  • personalized medicine
  • proteomics


Dive into the research topics of 'Personalized medicine in oncology: Tailoring the right drug to the right patient'. Together they form a unique fingerprint.

Cite this